Wendy Saffell-Clemmer | Director - Research
Baxter BioPharmaceutical Solutions | United States

Wendy Saffell-Clemmer, Director - Research, Baxter BioPharmaceutical Solutions

Wendy Saffell-Clemmer is the Director of the Baxter BioPharma Solutions R&D team.  The team offers contract development services for small volume liquid (vial and syringe) and lyophilized products which are manufactured for external clients both at Baxter’s Bloomington, IN, US and Halle, Germany facilities.  The services include formulation development, lyophilization cycle development, container compatibility and analytical development for small molecules, peptides, proteins, mAbs, ADCs and vaccines.  Additionally, the team performs analytical method validation, transfer and lifecycle maintenance for the QC group, as well as cleaning validation method development and validation.  Wendy volunteers as a member of the USP Expert Committee for Biological Analysis-General Chapters, the USP Expert Panel for Protein Measurement, and the AAPS Biosimilars Focus Group Steering Committee.

Appearances:



DC Co-conference Day 2 April 4 @ 12:40

Analytical characterization of aluminum adsorbed vaccines: Stability indicating methods for product release

  • What general guidance is there on release and stability test methods for aluminum adsorbed vaccines?  
  • Understanding of the antigen stability following adsorption
  • Reviewing potential release tests and proposing a panel of stability indicating tests for aluminum adsorbed vaccines

back to speakers